Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mitochondrial bioenergetics and cardiolipin remodeling abnormalities in mitochondrial trifunctional protein deficiency
Eduardo Vieira Neto, Meicheng Wang, Austin J. Szuminsky, Lethicia Ferraro, Erik Koppes, Yudong Wang, Clinton Van’t Land, Al-Walid Mohsen, Geancarlo Zanatta, Areeg H. El-Gharbawy, Tamil S. Anthonymuthu, Yulia Y. Tyurina, Vladimir A. Tyurin, Valerian Kagan, Hülya Bayır, Jerry Vockley
Eduardo Vieira Neto, Meicheng Wang, Austin J. Szuminsky, Lethicia Ferraro, Erik Koppes, Yudong Wang, Clinton Van’t Land, Al-Walid Mohsen, Geancarlo Zanatta, Areeg H. El-Gharbawy, Tamil S. Anthonymuthu, Yulia Y. Tyurina, Vladimir A. Tyurin, Valerian Kagan, Hülya Bayır, Jerry Vockley
View: Text | PDF
Research Article Genetics Metabolism

Mitochondrial bioenergetics and cardiolipin remodeling abnormalities in mitochondrial trifunctional protein deficiency

  • Text
  • PDF
Abstract

Mitochondrial trifunctional protein (TFP) deficiency is an inherited metabolic disorder leading to a block in long-chain fatty acid β-oxidation. Mutations in HADHA and HADHB, which encode the TFP α and β subunits, respectively, usually result in combined TFP deficiency. A single common mutation, HADHA c.1528G>C (p.E510Q), leads to isolated 3-hydroxyacyl-CoA dehydrogenase deficiency. TFP also catalyzes a step in the remodeling of cardiolipin (CL), a phospholipid critical to mitochondrial membrane stability and function. We explored the effect of mutations in TFP subunits on CL and other phospholipid content and composition and the consequences of these changes on mitochondrial bioenergetics in patient-derived fibroblasts. Abnormalities in these parameters varied extensively among different fibroblasts, and some cells were able to maintain basal oxygen consumption rates similar to controls. Although CL reduction was universally identified, a simultaneous increase in monolysocardiolipins was discrepant among cells. A similar profile was seen in liver mitochondria isolates from a TFP-deficient mouse model. Response to new potential drugs targeting CL metabolism might be dependent on patient genotype.

Authors

Eduardo Vieira Neto, Meicheng Wang, Austin J. Szuminsky, Lethicia Ferraro, Erik Koppes, Yudong Wang, Clinton Van’t Land, Al-Walid Mohsen, Geancarlo Zanatta, Areeg H. El-Gharbawy, Tamil S. Anthonymuthu, Yulia Y. Tyurina, Vladimir A. Tyurin, Valerian Kagan, Hülya Bayır, Jerry Vockley

×

Figure 4

Quantitative expression analysis of HADHA and HADHB alleles in TFP patient fibroblasts by reverse transcription droplet digital PCR assay.

Options: View larger image (or click on image) Download as PowerPoint
Quantitative expression analysis of HADHA and HADHB alleles in TFP patie...
Data are shown as 2-dimensional heatmaps with expression of HADHA/HADHB alleles on channel 1 vertical axis (6-carboxyfluorescein; FAM) and GAPDH (hexachloro-fluorescein; HEX) on channel 2 horizontal axis. Note that GAPDH fluorescence reached near saturation in all samples. Amplitude plots highlighting density in C and D and colored plots for double-positive droplet concentrations for reference (dark green) and variant (orange) expression in A, B, and E–H. Var, variant. (A and B) Assay assessing HADHA c.1528C LCHAD common variant shows a low-amplitude-positive cluster found in FB826 control cDNA that is shifted toward higher amplitude in FB822 cDNA, suggesting that the LCHAD mRNA is expressed. (C and D) The HADHA c.403A reference probe shows a single population of positive droplets in control FB826 but 2 clusters in FB847, indicating that both variant alleles HADHA c.2146+1G>A and c.403A>G are expressed. (E and F) Assay assessing HADHB c.881C reference allele expression in FB826 and FB861 reveals a single cluster in FB826 that is greatly diminished in FB861, consistent with degradation of the frameshift allele HADHB c.693delC. (G and H) Assay assessing HADHB c.881G variant allele verified that it is found only in FB861. Control FB826 shows a very low channel 1 amplitude cluster.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts